Novaxomx Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Novaxomx General Information

Description

Developer of biosurgical therapies designed to optimize biomimetic, osteoconductive carrier materials by biologizing them with substances that promote growth and healing. The company's biosurgical therapies are based on exosome, a bioactive nanovesicle secreted from human stem cells or derived from autologous platelets that facilitates intercellular communication and tissue regeneration, enabling surgeons and physicians to bring about improved biofunctionality and availability in regenerative processes such as bone fractures that are difficult to heal, bone fusion after spinal fusion and other musculoskeletal diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • University Hospital Jena
  • Eisenberg
  • Germany
Primary Industry
Biotechnology
Corporate Office
  • University Hospital Jena
  • Eisenberg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novaxomx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novaxomx‘s full profile, request access.

Request a free trial

Novaxomx Patents

Novaxomx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4631535-A1 Compounds for use as bone replacement and/or bone rebuilding material Inactive 11-Apr-2024
WO-2025214820-A1 Compounds for use as bone replacement and/or bone rebuilding material Pending 11-Apr-2024

Novaxomx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novaxomx‘s full profile, request access.

Request a free trial

Novaxomx FAQs

  • When was Novaxomx founded?

    Novaxomx was founded in 2022.

  • Where is Novaxomx headquartered?

    Novaxomx is headquartered in Eisenberg, Germany.

  • What industry is Novaxomx in?

    Novaxomx’s primary industry is Biotechnology.

  • Is Novaxomx a private or public company?

    Novaxomx is a Private company.

  • What is Novaxomx’s current revenue?

    The current revenue for Novaxomx is .

  • Who are Novaxomx’s investors?

    Curasan and Xlife Sciences have invested in Novaxomx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process